期刊文献+

宫颈癌组织中miR-100表达量与顺铂耐药的关系研究 被引量:2

Relationship between miR-100 expression in cervical cancer tissue and cisplatin resistance
下载PDF
导出
摘要 目的:研究宫颈癌组织中miR-100表达量与顺铂耐药的关系。方法:收集在本院接受顺铂化疗的107例宫颈癌组织作为临床样本,根据化疗效果分为化疗有效的顺铂敏感宫颈癌组织和化疗无效的顺铂敏感宫颈癌组织。检测miR-100的表达量及耐药相关基因、细胞周期相关基因及细胞侵袭相关基因的表达量。结果:顺铂耐药的宫颈癌组织中miR-100的表达量显著低于顺铂敏感的宫颈癌组织,Nek2、P-gp、GST-π、Topo-II、SP2、CyclinD1、CyclinG1、CDK4、CDK5、MMP1、PAR1、RbAp48、Vimentin、N-cadherin的表达量显著高于顺铂敏感的宫颈癌组织;miR-100的表达量与Nek2、P-gp、GST-π、Topo-II、SP2、CyclinD1、CyclinG1、CDK4、CDK5、MMP1、PAR1、RbAp48、Vimentin、N-cadherin的表达量呈负相关。结论:宫颈癌组织中miR-100的低表达与顺铂耐药密切相关。 Objective:To study the relationship between miR-100 expression in cervical cancer tissue and cisplatin resistance.Methods:107cases of cervical cancer tissues from those who received cisplatin chemotherapy in Huanggan Central Hospital between May 2013 and October 2013 were collected as the clinical samples and divided into chemotherapy-responsive cisplatin-sensitive cervical cancer tissue and chemotherapy-irresponsive cisplatin-sensitive cervical cancer tissue according to the curative effect of chemotherapy.The miR-100 expression as well as the expression of drug resistance-related genes,cell cyclerelated genes and cell invasion-related genes was detected.Results:miR-100 expression in cisplatin-resistant cervical cancer tissue was significantly lower than that in cisplatin-sensitive cervical cancer tissue while Nek2,P-gp,GST-π,Topo-II,SP2,CyclinD1,CyclinG1,CDK4,CDK5,MMP1,PAR1,RbAp48,Vimentin and N-cadherin expression were significantly higher than those in cisplatin-sensitive cervical cancer tissue;the miR-100 expression was negatively correlated with Nek2,P-gp,GST-π,Topo-II,SP2,CyclinD1,CyclinG1,CDK4,CDK5,MMP1,PAR1,RbAp48,Vimentin and N-cadherin expression.Conclusion:The lower expression of miR-100 in cervical cancer tissue is closely associated with cisplatin resistance.
出处 《海南医学院学报》 CAS 2017年第9期1251-1254,共4页 Journal of Hainan Medical University
基金 长江大学黄冈临床医学院(WJ2016-YZ-44)~~
关键词 宫颈癌 顺铂 耐药性 miR-100 细胞周期 Cervical cancer Cisplatin Drug resistance miR-100 Cell cycle
  • 相关文献

参考文献8

二级参考文献112

  • 1石永利,吴鸿雁,樊祥山,张明逸,叶庆,冯振卿.上皮-间叶转变相关蛋白在非小细胞肺癌中的表达及其预后意义[J].中国癌症杂志,2011,21(5):342-347. 被引量:12
  • 2陈鲲,李明珠,李淼,李建华.Twist、E-cadherin和Vimentin在非小细胞肺癌中的表达及意义[J].辽宁大学学报(自然科学版),2011,38(3):235-240. 被引量:7
  • 3高国兰,万红英,邹学森,陈文学,陈岳青,黄秀珍.子宫颈癌组织三磷酸腺苷肿瘤体外药物敏感试验及其与耐药蛋白表达的关系[J].中华妇产科杂志,2007,42(3):201-205. 被引量:9
  • 4Didiano D,Hobert O. Molecular Architecture of a miRNA-Regulated 3' UTR[J].RNA-A PUBLICATION OF THE RNA SOCIETY,2008.1297-1317.
  • 5Sun J,Chen Z,Tan X. MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma[J].Medical oncology (Northwood London England),2013.411-420.
  • 6Antonia K,Michael M,Zeng XF. Review of microRNA deregulation in oral cancer.Part Ⅰ[J].J Oral Maxillofac Res,2011.e1.
  • 7Chen Z,Jin Y,Yu D. Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma[J].ORAL ONCOLOGY,2012.686-691.
  • 8Nagaraja AK,Creighton C J,Yu Z. A link between miR-100 and frap1/mtor in clear cell ovarian cancer[J].Molecular Endocrinology,2010.447-463.
  • 9Torres A,Torres K,Pesci A. Deregulation of miR-100,miR-99a and miR-199B in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma[J].BMC Cancer,2012.369-382.
  • 10Li BH,Zhou JS,Ye F. Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLk1 protein[J].EUROPEAN JOURNAL OF CANCER,2011.2166-2174.

共引文献59

同被引文献16

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部